(Q37064709)

English

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients

scientific article published on 06 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

18 August 2017

Comparative study on the immunogenicity between an HLA-A24-restricted cytotoxic T-cell epitope derived from survivin and that from its splice variant survivin-2B in oral cancer patients (English)

1 reference

Europe PubMed Central

18 August 2017

0 references

0 references

0 references

lip and oral cavity carcinoma

1 reference

based on heuristic

inferred from title

Giovanni Del Poeta

1 reference

ORCID Public Data File 2021

Toshihiko Torigoe

2

object named as

Toshihiko Torigoe

1 reference

Europe PubMed Central

18 August 2017

Yoshihiko Hirohashi

3

object named as

Yoshihiko Hirohashi

1 reference

Europe PubMed Central

18 August 2017

8

object named as

Noriyuki Sato

1 reference

Europe PubMed Central

18 August 2017

Akihiro Miyazaki

5

object named as

Akihiro Miyazaki

1 reference

Europe PubMed Central

18 August 2017

Hiroyoshi Hiratsuka

7

object named as

Hiroyoshi Hiratsuka

1 reference

Europe PubMed Central

18 August 2017

4

object named as

Satomi Idenoue

1 reference

Europe PubMed Central

18 August 2017

author name string

Jun-ichi Kobayashi

1

1 reference

Europe PubMed Central

18 August 2017

Akira Yamaguchi

6

1 reference

Europe PubMed Central

18 August 2017

publication date

6 January 2009

1 reference

Europe PubMed Central

18 August 2017

Journal of Translational Medicine

1 reference

Europe PubMed Central

18 August 2017

7

1 reference

Europe PubMed Central

18 August 2017

1

1 reference

Europe PubMed Central

18 August 2017

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

0 references

https://scigraph.springernature.com/pub.10.1186/1479-5876-7-1

0 references

Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin, a cancer target with an emerging role in normal adult tissues

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Molecular cloning and bioinformatics analysis of a novel spliced variant of survivin from human breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Peptide-based vaccination for colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

A potent immunogenic general cancer vaccine that targets survivin, an inhibitor of apoptosis proteins.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin splice variants regulate the balance between proliferation and cell death

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Role of survivin and its splice variants in tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Phase I clinical study of anti-apoptosis protein, survivin-derived peptide vaccine therapy for patients with advanced or recurrent colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin expression in oral squamous cell carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin, versatile modulation of cell division and apoptosis in cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Detection and induction of CTLs specific for SYT-SSX-derived peptides in HLA-A24(+) patients with synovial sarcoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

Control of apoptosis and mitotic spindle checkpoint by survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

29 September 2017

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

4 September 2018

Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

4 September 2018

Differential subcellular localization of functionally divergent survivin splice variants.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

4 September 2018

Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

4 September 2018

Survivin as prognostic factor in squamous cell carcinoma of the oral cavity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2627828

4 December 2018

Lack of toxicity of therapy-induced T cell responses against the universal tumour antigen survivin

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Persistence of survivin specific T cells for seven years in a melanoma patient During domplete remission

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of multiple HLA-A24-restricted HIV-1 CTL epitopes: strong epitopes are derived from V regions of HIV-1

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of survivin and its relationship to loss of apoptosis in breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19123955

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1479-5876-7-1

1 reference

Europe PubMed Central

18 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

18 August 2017

1 reference

Europe PubMed Central

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37064709&oldid=1744009008"